1. Home
  2. PII vs IRON Comparison

PII vs IRON Comparison

Compare PII & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polaris Inc.

PII

Polaris Inc.

HOLD

Current Price

$61.38

Market Cap

3.6B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$76.84

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PII
IRON
Founded
1954
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
PII
IRON
Price
$61.38
$76.84
Analyst Decision
Hold
Strong Buy
Analyst Count
11
11
Target Price
$62.27
$103.18
AVG Volume (30 Days)
715.1K
367.8K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
4.05%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,152,000,000.00
N/A
Revenue This Year
$1.20
N/A
Revenue Next Year
$4.51
$283.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.14
$40.00
52 Week High
$77.98
$99.50

Technical Indicators

Market Signals
Indicator
PII
IRON
Relative Strength Index (RSI) 39.33 45.22
Support Level $58.81 $70.73
Resistance Level $71.10 $82.89
Average True Range (ATR) 2.18 2.68
MACD -0.27 -0.49
Stochastic Oscillator 25.53 34.56

Price Performance

Historical Comparison
PII
IRON

About PII Polaris Inc.

Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational, utility, military, and commercial purposes, snowmobiles, and on-road vehicles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to pontoon and deck boat users. It is slated to divest its Indian motorcycle brand to Carolwood in the first quarter of 2026. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: